Stocks Explorer
Stocks
Sectors
Search
Oric Pharmaceuticals, Inc.(ORIC) News
Profile
Chart
News
Analysis
Holders
ORIC price today
by TradingView
Date
Title
Nov 2
ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533 in Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting
‹ Prev
Page
of 2
Next ›